Table 1.
Total | Controlled | Partly controlled | Uncontrolled | P value* | |
---|---|---|---|---|---|
Number of patients, N (%) | 626 | 146 (23.3%) | 184 (29.4%) | 296(47.3%) | |
Age, years (mean ± SD) | 43.9 ± 13.4 | 43.8 ± 14.1 | 44.2 ± 14.4 | 43.8 ± 12.5 | .95 |
Male/female | 308/318 | 73/76 | 88/95 | 147/147 | .92 |
Chronic rhinosinusitis | |||||
sNP | 48.2% | 44.9% | 48.4% | 49.6% | .68 |
wNP a | 51.8% | 55.1% | 51.6% | 50.4% | .68 |
Pharmaceutical treatment | |||||
Nasal corticosteroids | 45.2% | 39.9% | 44.8% | 43.5% | .54 |
Oral corticosteroids | 4.2% | 4.4% | 2.7% | 4.4% | .46 |
Antibiotics | 3.4% | 3.8% | 3.8% | 2.3% | .40 |
Inhaled corticosteroids | 15.5% | 17.4% | 16.9% | 13.6% | .47 |
Sinus surgery | |||||
Primary | 31.9% | 34.9% | 29.5% | 32.0% | .58 |
Revision | 20.3% | 20.8% | 19.1% | 20.7% | .90 |
Allergic rhinitis b | 48.2% | 54.6% | 44.8% | 47.1% | .20 |
Asthma c | |||||
Childhood onset | 8.5% | 9.8% | 8.8% | 7.3% | .76 |
Adulthood onset | 23.7% | 24.1% | 21.3% | 23.9% | .71 |
COPD d | 5.9% | 9.0% | 6.0% | 4.3% | .17 |
Smoking status | |||||
Current smoker | 11.8% | 11.4 | 9.8% | 13.3% | .52 |
Ex‐smoker | 18.6% | 18.8% | 20.8% | 17.0% | .59 |
Never smoker | 69.6% | 69.8% | 69.4% | 69.7% | 1.00 |
Unknown in 82 patients.
Unknown in 37 patients.
Unknown in 86 patients.
Unknown in 67 patients.
Comparison between controlled, partly controlled and uncontrolled groups.